§ Mr. Ashleyasked the Secretary of State for Social Services if the drug Quixalin is still being manufactured in the United Kingdom; if the Committee on Safety of Medicines, or its predecessor, the Committee on Safety of Drugs, granted a licence for the drug when it was approved for human use; if it is still used in the United Kingdom; and if sales abroad from the United Kingdom are permitted.
§ Dr. Vaughan[pursuant to his reply, 12 March 1981, c. 421.]: Quixalin was first marketed in the United Kingdom in 1965 at which time there was no statutory requirement for medicinal products to be licenced. The Company concerned, however, voluntarily submitted data to the Committee on Safety of Drugs which found no reason to object to the drug being marketed. In 1971 the company was, on application, automatically granted a product licence of right for Quixalin in accordance with the provisions of the Medicines Act 1968 without the need to submit the evidence of safety, quality and efficacy which is now required for new products.
The product licence of right was cancelled in 1979, at the company's request, and I understand that Quixalin is no longer either manufactured or available in or exported from the United Kingdom.